Predicting Drug-Drug Interactions Involving the Inhibition of Intestinal CYP3A4 and P-Glycoprotein

By  

Current Drug Metabolism, Vol. 11, Iss. 9, 2010-11 ,pp. : 762-777

Bentham Science Publishers

Access to resources Recommend Favorite

Strategies to overcome simultaneous P-glycoprotein mediated efflux and CYP3A4 mediated metabolism of drugs

By Patel Jignesh   Mitra Ashim K  

Pharmacogenomics, Vol. 2, Iss. 4, 2001-11 ,pp. : 401-415

Future Medicine

Access to resources Recommend Favorite

Evaluation of Drug Interactions with P-Glycoprotein in Drug Discovery: In Vitro Assessment of the Potential for Drug-Drug Interactions with P-Glycoprotein

By  

Current Drug Metabolism, Vol. 3, Iss. 3, 2002-06 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite

P-glycoprotein Potentiates CYP3A4-mediated Drug Disappearance during Caco-2 Intestinal Secretory Detoxification

By Chan Lauretta M.S.   Cooper Anne E.   Dudley Adam L.J.   Ford Dianne   Hirst Barry H.  

Journal of Drug Targeting, Vol. 12, Iss. 7, 2004-08 ,pp. : 405-413

Informa Healthcare

Access to resources Recommend Favorite

The guinea‐pig expresses functional CYP2C and P‐glycoprotein: further validation of its usefulness in drug biotransformation/transport studies

By  

Biopharmaceutics And Drug Disposition, Vol. 36, Iss. 3, 2015-04 ,pp. : 183-203

John Wiley & Sons Inc

Access to resources Recommend Favorite